SG Americas Securities LLC Sells 741 Shares of National Health Investors, Inc. (NHI)
SG Americas Securities LLC lowered its position in National Health Investors, Inc. (NYSE:NHI) by 14.1% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,516 shares of the real estate investment trust’s stock after selling 741 shares during the quarter. SG Americas Securities LLC’s holdings in National Health Investors were worth $358,000 as of its most recent SEC filing.
Other institutional investors have also recently modified their holdings of the company. Carroll Financial Associates Inc. purchased a new position in National Health Investors in the second quarter worth approximately $158,000. Quantbot Technologies LP purchased a new stake in shares of National Health Investors during the 1st quarter worth approximately $201,000. Daiwa Securities Group Inc. lifted its position in shares of National Health Investors by 1.7% during the 1st quarter. Daiwa Securities Group Inc. now owns 3,200 shares of the real estate investment trust’s stock worth $232,000 after buying an additional 55 shares during the last quarter. Teacher Retirement System of Texas lifted its position in shares of National Health Investors by 2.0% during the 2nd quarter. Teacher Retirement System of Texas now owns 3,192 shares of the real estate investment trust’s stock worth $253,000 after buying an additional 62 shares during the last quarter. Finally, Tudor Investment Corp ET AL purchased a new stake in shares of National Health Investors during the 1st quarter worth approximately $262,000. Institutional investors own 70.58% of the company’s stock.
NHI has been the subject of several recent analyst reports. Bank of America Corporation downgraded shares of National Health Investors from a “neutral” rating to an “underperform” rating and set a $76.00 price objective for the company. in a research report on Monday, May 22nd. ValuEngine downgraded shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, June 13th. Stifel Nicolaus boosted their price objective on shares of National Health Investors from $80.00 to $82.00 and gave the stock a “buy” rating in a research report on Wednesday, June 21st. Mizuho restated a “neutral” rating on shares of National Health Investors in a research report on Wednesday, June 28th. Finally, BidaskClub upgraded shares of National Health Investors from a “hold” rating to a “buy” rating in a research report on Thursday, June 29th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the stock. National Health Investors presently has an average rating of “Hold” and an average target price of $81.40.
In other news, insider Kevin Carlton Pascoe sold 2,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 24th. The shares were sold at an average price of $79.80, for a total transaction of $159,600.00. Following the completion of the sale, the insider now owns 21,228 shares of the company’s stock, valued at $1,693,994.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 5.19% of the stock is currently owned by company insiders.
Shares of National Health Investors, Inc. (NYSE:NHI) opened at 79.70 on Thursday. National Health Investors, Inc. has a 52-week low of $66.31 and a 52-week high of $81.29. The stock has a market cap of $3.27 billion, a P/E ratio of 20.47 and a beta of 0.56. The company has a 50-day moving average of $78.33 and a 200 day moving average of $75.86.
National Health Investors (NYSE:NHI) last released its quarterly earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share for the quarter, missing analysts’ consensus estimates of $1.29 by ($0.36). National Health Investors had a return on equity of 12.56% and a net margin of 59.24%. The company had revenue of $69.84 million for the quarter, compared to analyst estimates of $67.68 million. During the same period in the previous year, the business posted $1.22 EPS. The firm’s quarterly revenue was up 14.1% compared to the same quarter last year. Equities research analysts forecast that National Health Investors, Inc. will post $3.85 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, November 10th. Stockholders of record on Friday, September 29th will be given a dividend of $0.95 per share. This represents a $3.80 dividend on an annualized basis and a dividend yield of 4.77%. The ex-dividend date of this dividend is Thursday, September 28th. National Health Investors’s payout ratio is currently 97.69%.
About National Health Investors
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.